herp
simplex
viru
type
import
pathogen
human
discoveri
novel
effect
antiherpet
drug
without
advers
effect
great
interest
primari
symptom
herp
infect
includ
prodrom
flulik
syndrom
fever
headach
malais
diffus
myalgia
follow
local
symptom
consist
itch
pain
papul
gingivostomat
pharyng
frequent
clinic
manifest
first
episod
infect
establish
latenc
hsv
reactiv
caus
frequent
recurr
infect
patient
wherea
peopl
experi
recurr
clinic
manifest
diseas
exhibit
differ
sever
immunocompet
patient
addit
patient
alway
encount
recurr
attack
howev
immunocompromis
patient
neonat
herpet
infect
caus
seriou
system
ill
recurr
herp
labiali
frequent
clinic
manifest
reactiv
infect
effect
treatment
hsv
avail
sinc
introduct
acyclovir
still
commonli
use
chemotherapi
antivir
agent
use
shorten
cours
decreas
sever
clinic
symptom
may
suppress
viru
antivir
agent
licens
current
treatment
herpesviru
infect
includ
acyclovir
deriv
foscarnet
cidofovir
inhibit
herpesviru
dna
polymeras
antivir
agent
might
produc
toxic
sideeffect
addit
emerg
viru
strain
resist
commonli
use
antiherpesviru
drug
import
particularli
immunocompromis
patient
develop
viral
resist
toward
antivir
agent
enhanc
need
new
effect
compound
viral
infect
thu
new
antivir
agent
exhibit
differ
mechan
action
urgent
need
medicin
plant
produc
varieti
chemic
constitu
potenti
inhibit
viral
replic
compound
natur
sourc
interest
possibl
sourc
control
viral
infect
plant
wide
use
treat
varieti
infecti
noninfecti
diseas
repres
abund
sourc
new
bioactiv
secondari
metabolit
thu
plant
continu
major
sourc
new
lead
compound
besid
small
molecul
medicin
chemistri
natur
product
still
major
sourc
innov
therapeut
agent
variou
condit
includ
infecti
diseas
recent
year
increas
interest
use
natur
substanc
question
concern
safeti
synthet
compound
encourag
detail
studi
plant
resourc
essenti
oil
odor
volatil
product
plant
secondari
metabol
wide
applic
folk
medicin
well
fragranc
industri
essenti
oil
complex
natur
mixtur
volatil
secondari
metabolit
isol
plant
hydro
steamdistil
main
constitu
essenti
oil
exampl
monoterpen
sesquiterpen
phenylpropanoid
includ
carbohydr
alcohol
ether
aldehyd
keton
respons
fragrant
biolog
properti
aromat
medicin
plant
variou
essenti
oil
compon
possess
pharmacolog
effect
demonstr
antiinflammatori
antioxid
anticancerogen
properti
antiherp
screen
experi
medicin
plant
extract
plantderiv
secondari
metabolit
report
antibacteri
antifung
immunomodulatori
antiinflammatori
antirheumat
activ
describ
essenti
oil
antiherp
activ
sever
essenti
oil
differ
plant
sourc
well
constitu
essenti
oil
demonstr
previous
applic
tea
tree
oil
essenti
oil
melaleuca
alternifolia
treatment
recurr
herp
labiali
report
recent
antiherp
activ
eucalyptu
oil
australian
tea
tree
oil
thyme
oil
manuka
oil
previous
publish
medicin
plant
extract
tradit
thai
medicin
plant
show
pronounc
antibacteri
activ
methicillinresist
staphylococcu
aureu
christoph
et
al
perform
compar
studi
invitro
antimicrobi
activ
tea
tree
oil
special
refer
activ
phenylpropan
triterpen
sesquiterpen
test
antivir
activ
differ
herpesvirus
rhinoviru
howev
sesquiterpen
import
constitu
essenti
oil
analyz
systemat
antivir
potenti
report
describ
inhibit
viral
replic
sesquiterpen
exampl
triptofordin
thu
limit
inform
sesquiterpen
concern
inhibit
viral
replic
cycl
mode
antivir
action
present
avail
aim
present
studi
evalu
antivir
activ
select
sesquiterpen
import
constitu
essenti
oil
mode
antivir
action
sesquiterpen
viral
multipl
cycl
star
anis
essenti
oil
met
standard
demand
current
pharmacopoeia
literatur
data
obtain
caelo
hilden
germani
essenti
oil
rich
transanethol
consist
phenylpropanoid
transanethol
eugenol
purchas
roth
gmbh
karlsruh
germani
farnesol
oxid
purchas
sigmaaldrich
chemi
gmbh
taufkirchen
germani
phenylpropanoid
sesquiterpen
met
high
puriti
standard
high
content
eugenol
clove
oil
transanethol
star
anis
oil
report
previous
structur
formula
select
phenylpropanoid
sesquiterpen
constitu
present
figur
star
anis
oil
select
compound
dissolv
ethanol
dilut
medium
cell
cultur
experi
alway
result
ethanol
concentr
effect
cell
virus
acyclovir
commonli
use
antihsv
synthet
drug
purchas
glaxosmithklin
bad
oldeslo
germani
dissolv
steril
water
appli
refer
compound
cell
african
green
monkey
kidney
cell
grown
monolay
cultur
dulbecco
modifi
eagl
medium
dmem
gibco
karlsruh
germani
supplement
fetal
calf
serum
fc
gibco
karlruh
germani
u
penicillin
streptomycin
gibco
karlsruh
germani
monolay
remov
plastic
surfac
serial
passag
whenev
becam
confluent
cell
plate
onto
cultur
plate
cytotox
antivir
assay
respect
propag
atmospher
strain
ko
use
experi
virus
routin
grown
cell
viru
stock
cultur
prepar
supernat
infect
cell
store
infect
titer
determin
standard
plaqu
assay
confluent
cell
effect
star
anis
oil
phenylpropanoid
sesquiterpen
prolifer
cell
determin
tissu
cultur
plate
initi
densiti
cell
cytotox
assay
cell
seed
onto
plate
incub
h
medium
remov
fresh
dmem
contain
appropri
dilut
essenti
oil
compound
ad
onto
subconflu
cell
eight
replic
concentr
drug
well
contain
medium
ethanol
drug
also
includ
plate
control
day
incub
growth
medium
remov
viabil
drugtreat
cell
determin
standard
neutral
red
assay
neutral
red
dye
uptak
determin
measur
optic
densiti
od
elut
neutral
red
nm
spectrophotomet
mean
od
cellcontrol
well
assign
valu
cytotox
concentr
drug
reduc
viabl
cell
number
determin
doserespons
curv
addit
maximum
noncytotox
concentr
drug
determin
antivir
activ
star
anis
oil
phenylpropanoid
sesquiterpen
assay
plaqu
reduct
assay
viru
suspens
contain
plaqu
form
unit
pfu
incub
equal
volum
dmem
variou
concentr
star
anis
oil
phenylpropanoid
sesquiterpen
h
roomtemperatur
viru
allow
adsorb
cell
h
residu
inoculum
replac
medium
contain
methylcellulos
incub
day
monolay
fix
formalin
cultur
stain
crystal
violet
subsequ
plaqu
count
concentr
perform
three
replic
virusinfect
cell
well
contain
medium
ethanol
drug
also
includ
plate
control
inhibitori
concentr
express
antivir
activ
inhibit
plaqu
number
compar
untreat
control
determin
doserespons
curv
star
anis
oil
phenylpropanoid
sesquiterpen
ad
cell
viru
infect
maximum
noncytotox
concentr
alway
use
evalu
mode
antivir
action
cell
monolay
pretreat
drug
prior
inocul
viru
ad
oil
compound
medium
follow
incub
h
pretreat
hsv
drug
pfu
hsv
incub
medium
contain
drug
h
roomtemperatur
prior
infect
cell
effect
essenti
oil
compon
hsv
also
test
replic
period
addit
drug
cell
infect
overlay
medium
typic
perform
antivir
suscept
studi
assay
run
three
replic
plaqu
reduct
assay
carri
describ
number
plaqu
drugtreat
cell
virus
compar
untreat
control
well
contain
medium
ethanol
drug
also
includ
plate
control
select
index
si
determin
ratio
experi
perform
triplic
three
independ
experi
conduct
data
present
mean
sd
ttest
use
evalu
differ
test
control
pvalu
consid
statist
signific
star
anis
oil
six
select
phenylpropanoid
sesquiterpen
figur
serial
dilut
ethanol
ad
cell
cultur
medium
examin
effect
growth
viabil
tissu
cultur
cell
alway
result
ethanol
concentr
effect
cell
virus
day
incub
cell
viabil
cell
determin
neutral
red
assay
tabl
maximum
noncytotox
concentr
drug
determin
oxid
star
anis
oil
drug
reveal
lowest
cytotox
similar
result
found
valu
exampl
oxid
star
anis
oil
potenti
antivir
effect
star
anis
essenti
oil
select
compon
differ
essenti
oil
determin
vitro
incub
h
roomtemperatur
variou
concentr
star
anis
oil
transanethol
eugenol
farnesol
oxid
assay
untreat
virusinfect
cell
use
control
subsequ
aliquot
dilut
incub
cell
h
cell
wash
overlaid
drugfre
medium
incub
day
inhibitori
concentr
determin
wide
rang
eugenol
tabl
result
present
figur
b
viru
reduct
repres
averag
three
independ
experi
plaqu
reduct
assay
star
anis
oil
compound
exhibit
concentrationdepend
antivir
effect
star
anis
oil
si
effect
drug
slightli
superior
si
si
test
drug
hsv
calcul
ratio
essenti
oil
star
anis
abl
suppress
viral
multipl
figur
six
test
compound
transanethol
farnesol
suppress
herpesviru
infect
maximum
noncytotox
concentr
drug
investig
inhibitori
effect
hsv
detail
drug
ad
differ
stage
viral
infect
comparison
untreat
control
contain
concentr
ethanol
drugtreat
virus
order
exclud
influenc
ethanol
host
cell
pretreat
drug
prior
infect
none
test
drug
show
statist
signific
effect
p
viral
infect
figur
hand
pretreat
star
anis
oil
phenylpropanoid
sesquiterpen
prior
infect
inhibit
herpesviru
infect
maximum
noncytotox
concentr
test
drug
infect
reduc
star
anis
oil
follow
reduct
figur
b
constitu
essenti
oil
reveal
plaqu
reduct
hsv
howev
antivir
effect
eugenol
statist
signific
p
acyclovir
show
highest
antivir
activ
ad
replic
period
inhibit
viral
replic
data
shown
drug
inhibit
specif
viral
dna
polymeras
replic
cycl
new
viral
dna
synthes
contrast
oil
compound
ad
overlay
medium
penetr
virus
host
cell
plaqu
format
significantli
p
reduc
figur
pharmaceut
industri
increasingli
target
medicin
plant
aim
identifi
lead
compound
focus
particularli
suitabl
altern
antivir
agent
topic
treatment
herp
labiali
infect
standard
part
carri
acyclovir
cream
also
phytopharmaceut
contain
sage
lemon
balm
extract
plant
extract
shown
significantli
superior
placebo
equival
acyclovir
previou
invitro
experi
reveal
similar
result
essenti
oil
eucalyptu
tea
tree
thyme
present
studi
inhibitori
effect
star
anis
oil
hsv
infect
compar
antivir
potenti
phenylpropanoid
sesquiterpen
compound
experi
assess
cytotox
essenti
oil
monoterpen
cultur
eukaryot
cell
indic
moder
toxic
behavior
cell
cultur
accord
hall
star
anis
essenti
oil
compound
exhibit
high
level
antivir
activ
viral
suspens
test
maximum
noncytotox
concentr
plaqu
format
significantli
reduc
star
anis
oil
phenylpropanoid
sesquiterpen
abl
suppress
viral
infect
respect
mode
antivir
action
determin
time
addit
assay
pretreat
cell
drug
effect
product
infecti
viru
plaqu
format
result
found
star
anis
oil
compound
ad
replic
period
infect
cycl
howev
high
antivir
activ
observ
star
anis
oil
transanethol
farnesol
herpesviru
incub
drug
prior
host
cell
infect
figur
result
suggest
drug
directli
inactiv
herp
viru
might
interfer
virion
envelop
structur
mask
viral
structur
necessari
adsorpt
entri
host
cell
virucid
activ
melaleuca
armillari
essenti
oil
report
recent
dissolut
hsv
envelop
treatment
oregano
essenti
oil
describ
thu
differ
mechan
antivir
activ
differ
essenti
oil
compound
essenti
oil
seem
present
de
logu
et
al
report
inactiv
herpesvirus
prevent
celltocel
spread
santolina
insulari
essenti
oil
howev
antivir
effect
observ
intracellular
replic
phase
accord
result
essenti
oil
adenoviru
viru
without
envelop
affect
eucalyptu
essenti
oil
due
lack
viral
envelop
sesquiterpen
exampl
triptofordin
sesquiterpen
coumarin
inhibit
cytomegaloviru
sever
acut
respiratori
syndrom
coronaviru
rhinoviru
pusztai
et
al
report
specif
inhibit
cmv
immedi
earli
gene
express
wherea
sesquiterpen
moder
virucid
differ
envelop
virus
exampl
hsv
cytomegaloviru
measl
viru
influenza
viru
eugenol
phenylpropan
repres
vv
clove
essenti
oil
delay
develop
herpesvirusinduc
kerat
mous
model
inactiv
hsv
directli
direct
inactiv
viru
particl
eugenol
repres
antivir
mechan
examin
constitu
studi
isoborneol
monoterpen
compon
sever
plant
essenti
oil
show
virucid
activ
specif
inhibit
glycosyl
viral
protein
applic
cineol
protect
mice
infect
sinc
essenti
oil
abl
inhibit
acyclovirresist
isol
mechan
interact
compound
acyclovir
hsv
must
differ
acyclovir
inhibit
viru
replic
interfer
dna
polymeras
insid
cell
wherea
star
anis
oil
phenylpropanoid
sesquiterpen
probabl
inactiv
hsv
enter
cell
viral
resist
acyclovir
repres
particular
problem
preval
resist
acyclovirtr
immunocompromis
individu
therefor
antiherpet
agent
effect
viral
mutant
resist
current
antivir
agent
great
interest
topic
treatment
applic
tea
tree
oil
essenti
oil
melaleuca
alternifolia
treatment
recurr
herp
labiali
report
recent
complex
mixtur
essenti
oil
reveal
higher
antivir
activ
si
wherea
singl
constitu
reveal
lower
select
indic
howev
reveal
si
rang
index
valu
star
anis
oil
found
mani
differ
essenti
oil
differ
plant
famili
thu
might
one
domin
antivir
agent
differ
essenti
oil
antivir
potenti
test
compound
studi
trace
back
structur
featur
sesquiterpen
hydrocarbon
activ
antivir
compound
introduct
either
epoxid
hydroxyl
function
sesquiterpen
backbon
led
moder
decreas
antivir
effect
co
et
al
recommend
valu
promis
natur
product
infecti
diseas
exampl
extract
star
anis
essenti
oil
studi
reveal
valu
far
recommend
cutoff
present
promis
antiinfect
agent
accord
recommend
conclus
medicin
aromat
plant
wide
use
today
modern
phytotherapi
essenti
oil
compon
known
activ
wide
varieti
microorgan
phenylpropanoid
sesquiterpen
present
essenti
oil
contribut
antivir
activ
drug
high
si
prefer
antivir
treatment
patient
thu
star
anis
oil
complex
mixtur
singl
constitu
might
appli
topic
therapeut
agent
treatment
recurr
herp
infect
grant
iranian
ministri
health
astani
